Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats.
about
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next StepFragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitorsEffects of exogenous thymosin β4 on carbon tetrachloride-induced liver injury and fibrosisProlyl oligopeptidase attenuates hepatic stellate cell activation through induction of Smad7 and PPAR-γ.The emerging role of mast cells in liver disease.Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.
P2860
Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Antifibrotic effect of N-acety ...... nduced liver fibrosis in rats.
@ast
Antifibrotic effect of N-acety ...... nduced liver fibrosis in rats.
@en
type
label
Antifibrotic effect of N-acety ...... nduced liver fibrosis in rats.
@ast
Antifibrotic effect of N-acety ...... nduced liver fibrosis in rats.
@en
prefLabel
Antifibrotic effect of N-acety ...... nduced liver fibrosis in rats.
@ast
Antifibrotic effect of N-acety ...... nduced liver fibrosis in rats.
@en
P2093
P2860
P356
P1476
Antifibrotic effect of N-acety ...... nduced liver fibrosis in rats.
@en
P2093
Chun-Ying Qu
Lei-Ming Xu
Qian-Wen Ni
Yuan-Wen Chen
P2860
P304
P356
10.3748/WJG.V18.I37.5283
P407
P577
2012-10-01T00:00:00Z